Eskayef Pharmaceuticals Ltd.


Eskayef Pharmaceuticals Ltd., also known as SK+F, is one of top leading pharmaceutical companies in Bangladesh. It belongs to the Transcom Group. Ms Simeen Hossain is the managing director & CEO of the company.

History

Eskayef Bangladesh Limited, a successor of Smith, Kline & French in Bangladesh, was acquired by Transcom in 1990. According IMS report, the company placed among the top six pharmaceutical companies operating in Bangladesh in terms of sales. It exports finished products to more than 30 countries across 4 continents including Asia, Europe, Australia and Africa. The company was renamed Eskayef Pharmaceuticals Limited in January 2017. In May 2020, during COVID-19 Pandemic, Eskayef becomes the global headline in print & electronic media as it has started manufacturing of the only USFDA authorized treatment option Remdesivir injection with the brand name Remivir, which is the 1st generic version of Remdesivir in the world.
The company is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products.